The market's leading competitors are concentrating on R&D efforts to create cutting-edge methods and medications for treating brain haemorrhage, which is anticipated to propel market growth for brain haemorrhage throughout the forecast period. For instance, a U.S.-based medical device firm called Penumbra Inc. started randomising clinical trials in February 2018 to examine the effectiveness of its Artemis neuro evacuation device, a minimally invasive method for removing hematomas (masses of blood) in the event of a brain haemorrhage. There are 500 participants in this clinical research, which should be finished by July 2025.
The global Brain Hemorrhage Market is estimated to be valued at US$ 179.8 million in 2021 and is expected to exhibit a CAGR of 6.0% over the forecast period (2021-2028).
Top Companies in the Brain Hemorrhage Industry:
1. Baxter International, Inc.
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois. The company is operational in more than 100 countries.
2. Oxurion NV
Oxurion NV, a biopharmaceutical company, develops and commercializes medicines for the treatment of eye diseases in Belgium and internationally. Oxurion NV was founded in 1991 and is headquartered in Leuven, Belgium.
3. Pfizer Inc.
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. on December 2022, Pfizer Presents Updated Favorable Elranatamab Data from Pivotal Phase 2 MagnetisMM-3 Trial, early and deep responses, and a manageable safety profile for elranatamab in heavily pretreated patients with advanced multiple myeloma
4. F. Hoffmann-La Roche Ltd.
Roche Holding AG engages in the pharmaceuticals and diagnostics. The company was founded in 1896 and is headquartered in Basel, Switzerland.
5. Boehringer Ingelheim GmbH
Founded in 1885 leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. In June, 2022
Boehringer Ingelheim launches Fencovis®, a new vaccine to prevent calf diarrhea.
6. Novartis International AG
Novartis AG researches, develops, manufactures, and markets healthcare products in Switzerland and internationally. The company operates through two segments: Innovative Medicines and Sandoz. Novartis AG was incorporated in 1996 and is headquartered in Basel, Switzerland. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran, a therapy to reduce LDL cholesterol.
7. Bayer AG
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany.
8. Abbott
Abbott is a global healthcare leader in medical products and devices manufacturing. It serves people in more than 160 countries. Abbott was established in 1888. Abbott launched its Navitor its latest generation transcatheter aortic valve implantation (TAVI) system to treat Aortic Stenosis in India.
9. Bristol-Myers Squibb Company
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products globally from 1887. The company was headquartered in New York, New York. In September, 2022 announced that the U.S. Food and Drug Administration (FDA) approved Sotyktu™ (deucravacitinib), a first-in-class, oral, selective, allosteric tyrosine kinase 2 (TYK2) inhibitor, for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy.
10. Johnson & Johnson
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company was founded in 1886 and is based in New Brunswick, New Jersey. On October 2022, The U.S. Food and Drug Administration (FDA) has approved Johnson & Johnson's therapy for treating a type of multiple myeloma, the company said on Tuesday, giving another treatment option to patients with the incurable blood cancer.
*Definition- A brain haemorrhage, often referred to as a brain bleed or an intracranial haemorrhage, is a potentially fatal medical disorder in which a blood vessel bursts, resulting in bleeding inside the brain or on its surface.
